Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)

Clinical trial NCT06138353 · UNKNOWN

Trial details

NCT number: NCT06138353
Sponsor: Xiaolin Chen, MD
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Subarachnoid Hemorrhage, Aneurysmal

Start date: 2024-01-24
Primary completion: 2025-11-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.